29-30 June – 1 July 2027, Eigtveds Pakhus, Copenhagen, Denmark
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2027 will offer researchers a fresh forum to discuss this important topic in detail.
MVADS 2027 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.
Scientific Advisory Panel
Conference Chairmen:
Dennis Christensen (CRODA Denmark, Frederikssund, Denmark)
Gabriel Pedersen (Statens Serum Institut, Copenhagen, Denmark)
James Brewer (University of Glasgow, Glasgow, Scotland, UK)
Martin Bachmann (Inselspital, Bern, Switzerland / University of Oxford, Oxford, UK)
Jean Haensler (Sanofi, Marcy L’Etoile, France)
Derek O’Hagan (GSK Vaccine Research, Cambridge, Massachusetts, USA)
Stefan Jungbluth (European Vaccine Initiative (EVI), Heidelberg, Germany)
Ken Ishi (IMS/University of Tokyo, Tokyo, Japan)
Edward Lavelle (Trinity College Dublin, Dublin, Ireland)
Arnaud Didier-Laurent (University of Geneva, Geneva, Switzerland)
Sabine Wellnitz (Pfizer Inc., Pearl River, New York, USA)
Emanuele Montomoli (VisMederi Holdings/University of Siena, Siena, Italy)
Sean Tucker (VAXART Inc, South San Francisco, California, USA)
Ali Harandi (European Vaccine Initiative, EVI, Heidelberg, Germany)
Yvonne Perrie (University of Strathclyde, Glasgow, Scotland, UK)
Virgil Schijns (SwiftPharma BV, Gent, Belgium)
Mona Muhsen (Inselspital, Bern, Switzerland)
Anne Moore (University College Cork, Cork, Ireland)
Thomas Courant (Vaccine Formulation Institute, Epalinges, Switzerland) Camilla Foged (University of Copenhagen, Copenhagen, Denmark)
Else Marie Agger (NIVI/NOVO Nordisk Foundation, Copenhagen, Denmark)
David Muller (University of Queensland, Brisbane, Queensland, Australia)
Zoltan Beck (Desert King International, Chula Vista, California, USA)
Bingbing Sun (Dalian University of Technology, Dalian, China)
Conference Scope
Scientific Sessions:
- Mechanistic Interpretations
- Delivery
- Formulation & Design
- Modern Vaccines & Adjuvants
- Safety
- Regulation
- Future Developments